Rapport Therapeutics aims to transform the treatment of neurological disorders through a precision medicine approach, precisely targeting disease-driving neurocircuits by leveraging receptor-associated proteins (RAPs). With this approach, Rapport can overcome the well-established limitations of today’s neuromedicines that act indiscriminately throughout the nervous system, resulting in suboptimal efficacy and burdensome side effects. Leading the hunt for precision medicines is a team with established track records of innovation in neuroscience and drug discovery. Rapport was conceptualized and created through a partnership between Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc. (JJDC) and launched in March 2023. Rapport is based in San Diego, CA and Boston, MA. For more information, please visit www.rapportrx.com.

Rapport Therapeutics

Our CEO, Abraham (Abe) Ceesay, participated in a fireside chat at the first ever Boston While Black (BWB) Biotech & Life Sciences industry mixer held at Entrada Therapeutics at the end of #BlackHistoryMonth. There, he was able to share insights from his own experiences navigating his career journey in the world of #BostonBiotech with an audience of early to executive-level Black professionals.  Thank you to BWB for the opportunity!

This morning, we announced the appointment of Kathy Wilkinson as Chief People Officer. Kathy joins us with over 20 years of human resource experience in the #biopharma world. As Rapport continues to grow, Kathy will be invaluable to shaping our people and patient focused culture. We are thrilled to welcome you aboard, Kathy!  
 

We are pleased to share that the National Institute of Neurological Disorders and Stroke (NINDS) has granted Rapport acceptance into the Preclinical Screening Platform for Pain (PSPP) program, which evaluates assets for novel #pain #therapeutics through preclinical studies. This is a tremendous honor and further validates the direction we’re taking with our scientific approach. Learn more about the PSPP program on the NINDS website here: http://bit.ly/492H23x

Today, we celebrate International Day of Women and Girls in Science, a day to reflect on the accomplishments of women in science everywhere and shine the spotlight on the ever-present need to support women and girls in their pursuit of STEM careers. We are humbled at Rapport to have incredible women colleagues who are beacons of strength and inspiration for the next generation of scientists. 
 
#WomenInScience #IDWGS #InternationalDayofWomenandGirlsinScience #WomenInSTEM

A warm welcome to Brian Corcoran who has joined our team as Controller. In this role, Brian will be responsible for all accounting procedures, processes, and financial reporting, as well as leading accounting teams. He will also partner with the management team on building financial infrastructure and policies that will support the company’s growth.
 
Glad to have you on the team, Brian!

Sarepta Therapeutics is a biotechnology company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular diseases.

Sarepta Therapeutics

LendingPad is a digital mortgage loan origination system that offers a comprehensive suite of tools for mortgage professionals.

LendingPad

Array is a company that provides innovative solutions in the healthcare technology sector, focusing on personalized patient support services and interventions.

Array

RapportRx is a healthcare technology company that specializes in providing patient support services and solutions to improve medication adherence and patient outcomes. The company leverages data analytics, patient engagement strategies, and a deep understanding of the patient journey to offer personalized support and interventions.

RapportRx

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 12, 2024 2:34 PM	a51cad35
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 11, 2024 10:30 AM	9c8c0fa0
crunchbase profile	general
li profile	general	May 12, 2024 2:34 PM	98c198c8
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 12, 2024 2:34 PM	f171fd3e
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:RAPPORTRX

RapportRx